However, increased levels of IGF2BP3 have been identified in many cancers including adenocarcinomas of the pancreas, kidney, lung, breast, esophagus, cervix, endometrium, and cutaneous melanomas [17]. The gene discussed is IGF2BP3; the disease is cancer.